According to a note from INLS, to which Lusa had access this Monday, the estimated value of the contract is 20,149,259,500 kwanzas, whose batches of medicines and other means must be distributed in six phases.
The first batch comprises antiretrovirals for adult use worth 836.9 million kwanzas, the second antiretrovirals for pediatric use worth 1.13 billion kwanzas, the third of first-line antiretrovirals worth 10.1 billion of kwanzas.
Rapid tests worth 4.2 billion kwanzas, laboratory reagents worth 2.3 billion kwanzas and condoms worth 1.4 billion kwanzas are part of the following batches.
For this public tender, via electronic auction, with a deadline of the 19th, the INLS determines that competitors must have registration or certification as a State supplier, proof of regularized status with Social Security and the Tax Administration.
They must also have authorization to import health products, issued by the Medicines and Health Technologies Regulatory Agency, and present financial statements for the last two years.
The Angolan Network of AIDS and Major Endemic Services Organizations (ANASO) estimates that in Angola there are around 350,000 people with HIV/AIDS, the majority of whom are women, with a prevalence rate of 2 percent.
Luanda, Lunda Norte, Lunda Sul, Moxico and Cunene are the provinces most affected by the disease, according to data from ANASO.
